Pattern of psychotropic medication use over two decades in Australian women. (December 2017)
- Record Type:
- Journal Article
- Title:
- Pattern of psychotropic medication use over two decades in Australian women. (December 2017)
- Main Title:
- Pattern of psychotropic medication use over two decades in Australian women
- Authors:
- Stuart, Amanda L
Mohebbi, Mohammadreza
Pasco, Julie A
Quirk, Shae E
Brennan-Olsen, Sharon L
Berk, Michael
Williams, Lana J - Abstract:
- Objective: Few population-based studies have been used to investigate secular trends in psychotropic medication use. Therefore, the aim of this study was to examine psychotropic medication use over time using data from the Geelong Osteoporosis Study, an on-going, population-based, cohort study of Australian women. Methods: Of the 1494 women recruited at Time 1 (1993–1997), self-reported medication use from Time 2 (2004–2008) and/or Time 3 (2011–2014) was available for 889 women. Prevalence of antidepressant/antipsychotic/anxiolytic/sedative/anticonvulsant use by age and cohort strata was calculated using bootstrapping methods. Simultaneous age-cohort patterns were evaluated using logistic regression techniques. Results: The prevalence of any psychotropic medication use increased from 8.0% (95% confidence interval = [6.3, 9.8]) at Time 1 to 26.0% (95% confidence interval = [22.4, 29.4]) at Time 3, translating to a 4.3-fold increase in the likelihood of psychotropic medication use over the study period (odds ratio = 4.3, 95% confidence interval = [3.2, 5.8], p < 0.001). This increase was driven by the use of antidepressants (odds ratio = 6.4, 95% confidence interval = [4.2, 9.5], p < 0.001) and anticonvulsants (odds ratio = 4.4, 95% confidence interval = [1.8, 11.1]) and modest increases in the use of anxiolytic agents (odds ratio = 1.9, 95% confidence interval = [1.1, 3.1]) and sedatives (odds ratio = 1.7, 95% confidence interval = [1.6, 1.9]). The prevalence of anyObjective: Few population-based studies have been used to investigate secular trends in psychotropic medication use. Therefore, the aim of this study was to examine psychotropic medication use over time using data from the Geelong Osteoporosis Study, an on-going, population-based, cohort study of Australian women. Methods: Of the 1494 women recruited at Time 1 (1993–1997), self-reported medication use from Time 2 (2004–2008) and/or Time 3 (2011–2014) was available for 889 women. Prevalence of antidepressant/antipsychotic/anxiolytic/sedative/anticonvulsant use by age and cohort strata was calculated using bootstrapping methods. Simultaneous age-cohort patterns were evaluated using logistic regression techniques. Results: The prevalence of any psychotropic medication use increased from 8.0% (95% confidence interval = [6.3, 9.8]) at Time 1 to 26.0% (95% confidence interval = [22.4, 29.4]) at Time 3, translating to a 4.3-fold increase in the likelihood of psychotropic medication use over the study period (odds ratio = 4.3, 95% confidence interval = [3.2, 5.8], p < 0.001). This increase was driven by the use of antidepressants (odds ratio = 6.4, 95% confidence interval = [4.2, 9.5], p < 0.001) and anticonvulsants (odds ratio = 4.4, 95% confidence interval = [1.8, 11.1]) and modest increases in the use of anxiolytic agents (odds ratio = 1.9, 95% confidence interval = [1.1, 3.1]) and sedatives (odds ratio = 1.7, 95% confidence interval = [1.6, 1.9]). The prevalence of any psychotropic medication use increased with increasing age (40–59.9 years: odds ratio = 1.9, 95% confidence interval = [1.5, 2.6]; 60–79.9 years: odds ratio = 2.6, 95% confidence interval = [1.9, 3.5], compared to the 20- to 39.9-year group). Use of selective serotonin reuptake inhibitors increased dramatically over the study period (odds ratio = 15.3, 95% confidence interval = [7.0, 33.4]). Conclusion: Use of psychotropic medication has increased substantially over the past two decades, especially among older women. Further investigations into the correlates and outcomes of the increased use of psychotropic medications are warranted. … (more)
- Is Part Of:
- Australian and New Zealand journal of psychiatry. Volume 51:Number 12(2017)
- Journal:
- Australian and New Zealand journal of psychiatry
- Issue:
- Volume 51:Number 12(2017)
- Issue Display:
- Volume 51, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 51
- Issue:
- 12
- Issue Sort Value:
- 2017-0051-0012-0000
- Page Start:
- 1212
- Page End:
- 1219
- Publication Date:
- 2017-12
- Subjects:
- Psychotropics -- antidepressants -- prescribing -- population -- drug utilisation
Psychiatry -- Periodicals
Psychiatry -- Australia -- Periodicals
Psychiatry -- New Zealand -- Periodicals
616.89005 - Journal URLs:
- http://anp.sagepub.com ↗
http://informahealthcare.com/journal/anp ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=anp ↗ - DOI:
- 10.1177/0004867417704056 ↗
- Languages:
- English
- ISSNs:
- 0004-8674
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1796.893000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7833.xml